NCT06318494

Brief Summary

The study is, in accordance with current legislation, definable as a single-center interventional study with evaluations carried out at a single timeframe. The objective of the study is to compare jumping performance between subjects with ankle instability and healthy volunteer subjects. In particular, the primary objective is to verify the difference in the monopodalic CMJ value of the diseased limb of subjects with ankle instability compared to the control group at time 0. The population is made up of patients suffering from ankle instability and a control group of healthy volunteers, divided as follows: 25 subjects GROUP A: Study group: patients suffering from ankle instability 25 subjects GROUP B: control group: healthy voluntary subjects not affected by ankle pathology

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 28, 2022

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

March 4, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 19, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

March 19, 2024

Status Verified

March 1, 2024

Enrollment Period

2.7 years

First QC Date

March 4, 2024

Last Update Submit

March 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • verify the difference in the monopodalic CMJ (countermovement jump test) of the diseased limb of subjects with ankle instability compared to the control group

    verify the difference in the monopodalic CMJ (countermovement jump test) value of the diseased limb of subjects with ankle instability compared to the control group at time 0

    Day 0

Study Arms (2)

Patients suffering from ankle instability

EXPERIMENTAL
Other: jumping performance

Healthy volunteer subjects not affected by ankle pathology

ACTIVE COMPARATOR
Other: jumping performance

Interventions

Patients suffering from chronic ankle instability symptomatic of recurrent subjective and objective instability will be considered. Patients will be compared to a control group of healthy volunteer subjects. T0 Explanation of the study and written informed consent. * Verification of inclusion/exclusion criteria and verification of previous or ongoing treatments. * AOFAS Rating Scales, * Tegner activity level * Vertical Jump Test (CMJ) by foot pedal

Healthy volunteer subjects not affected by ankle pathologyPatients suffering from ankle instability

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Athletes of legal age (aged between 18 and 45 years inclusive) suffering from chronic ankle instability symptomatic of recurrent subjective and objective instability (study group).
  • Athletes of legal age (aged between 18 and 45 years) who are not symptomatic for ankle diseases (control group)
  • Signing of the Informed Consent and consent to collaborate in all study procedures.

You may not qualify if:

  • Minors
  • Pregnant women (self-declaration)
  • patients with BMI ≥ 30
  • patients with orthopaedic, muscular and neuromuscular problems at the time of performing the jump
  • Non-acceptance of informed consent
  • Patients with previous unilateral or contralateral ankle reconstructive surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Clinico San Siro

Milan, Italy

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2024

First Posted

March 19, 2024

Study Start

April 28, 2022

Primary Completion

January 1, 2025

Study Completion

July 1, 2025

Last Updated

March 19, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations